These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 12465082

  • 1. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS.
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [Abstract] [Full Text] [Related]

  • 2. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
    Knol W, Keijsers CJ, Jansen PA, van Marum RJ.
    J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
    [Abstract] [Full Text] [Related]

  • 3. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 4. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [Abstract] [Full Text] [Related]

  • 5. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 6. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J.
    J Clin Psychiatry; 1999 Oct; 60 Suppl 23():20-4. PubMed ID: 10625196
    [Abstract] [Full Text] [Related]

  • 7. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL, Kelly MW.
    Am J Hosp Pharm; 1994 Apr 01; 51(7):895-9. PubMed ID: 7912473
    [Abstract] [Full Text] [Related]

  • 8. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity.
    Gerlach J, Korsgaard S, Clemmesen P, Lauersen AM, Magelund G, Noring U, Povlsen UJ, Bech P, Casey DE.
    Acta Psychiatr Scand; 1993 Apr 01; 87(4):244-52. PubMed ID: 8098178
    [Abstract] [Full Text] [Related]

  • 9. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct 01; 16(5):181-5. PubMed ID: 8962437
    [Abstract] [Full Text] [Related]

  • 10. Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.
    Peljto A, Zamurovic L, Milovancevic MP, Aleksic B, Tosevski DL, Inada T.
    Sci Rep; 2017 Aug 14; 7(1):8105. PubMed ID: 28808283
    [Abstract] [Full Text] [Related]

  • 11. The problem of tardive akathisia.
    Gualtieri CT.
    Brain Cogn; 1993 Sep 14; 23(1):102-9. PubMed ID: 8105819
    [Abstract] [Full Text] [Related]

  • 12. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M, Gorwood P, Stalla-Bourdillon A, Adès J.
    Encephale; 1993 Sep 14; 19(1):17-21. PubMed ID: 8275889
    [Abstract] [Full Text] [Related]

  • 13. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG, Kopala LC, Rabinowitz J.
    J Psychopharmacol; 2005 May 14; 19(3):277-85. PubMed ID: 15888513
    [Abstract] [Full Text] [Related]

  • 14. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun 14; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 15. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov 14; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 16. Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test-retest reliability.
    Weidle B, Chaulagain A, Stensen K, Aleksic B, Skokauskas N, Inada T.
    Nord J Psychiatry; 2019 Nov 14; 73(8):546-550. PubMed ID: 31532276
    [Abstract] [Full Text] [Related]

  • 17. The dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations.
    Kalachnik JE, Sprague RL.
    J Clin Psychol; 1993 Mar 14; 49(2):177-89. PubMed ID: 8098048
    [Abstract] [Full Text] [Related]

  • 18. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T, Hubmann W, Karr M, Mohr F, Schlenker R, Heidenreich T, Cohen R, Schröder J.
    Psychiatry Res; 2006 Jun 15; 142(2-3):191-9. PubMed ID: 16650902
    [Abstract] [Full Text] [Related]

  • 19. The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
    Kubota C, Inada T, Lin SK, Avasthi A, Chee KY, Tanra AJ, Yang SY, Chen LY, Chong MY, Tripathi A, Kallivayalil RA, Grover S, Park SC, Kato TA, Xiang YT, Sim K, Maramis MM, Noor IM, Tan CH, Sartorius N, Shinfuku N.
    Hum Psychopharmacol; 2023 Mar 15; 38(2):e2861. PubMed ID: 36462184
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales.
    de Kuijper GM, Hoekstra PJ.
    J Clin Psychopharmacol; 2016 Oct 15; 36(5):508-12. PubMed ID: 27529770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.